黑料网

Case Report

Multilineage Cytotoxic Treatment for Advanced Colorectal Cancer in Nonagenarians

Kathelijn S Versteeg^1,2, Susanne Blauwhoff-Buskermolen^1,3, Andrea B Maier^4,5, Inge R Konings¹ and Henk M W Verheul^1*

¹Medical Oncology, VU University Medical Center (VU mc) Amsterdam, Netherlands

²Internal Medicine, Section of Gerontology and Geriatrics, VU mc Amsterdam, Netherlands

³Department of Internal Medicine, Section of Nutrition and Dietetics, VU mc Amsterdam, Netherlands

⁴Department of Human Movement Sciences, MOVE Research Institute Amsterdam, VU University, Amsterdam, Netherlands

⁵Department of Medicine and Aged Care, Royal Melbourne Hospital, University of Melbourne, Victoria, Australia

*Corresponding Author:

Verheul HMW
Medical Oncology VU University Medical Center
Amsterdam, Netherlands
Tel: +31 (0)20-4444300
E-mail: h.verheul@vumc.nl

Received date: November 22, 2016; Accepted date: November 28, 2016; Published date: November 30, 2016

Citation: Versteeg KS, Blauwhoff-Buskermolen S, Maier AB, Konings IR, Verheul HMW (2016) Multilineage Cytotoxic Treatment for Advanced Colorectal Cancer in Nonagenarians. J Palliat Care Med 6:293. doi: 10.4172/2165-7386.1000293

Copyright: © 2016 Versteeg, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Decision making in older cancer patients is challenging. We present the case of a fit 90-year old patient with advanced colorectal cancer, focusing on the dilemmas we faced during multilineage systemic treatment. Although chemotherapy can be effective and tolerable in nonagenarians, current evidence on how to identify patients who will benefit from treatment is limited.

Keywords